Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies
Day 2 of CHDI’s HD therapeutics conference: figuring out energy problems in HD
Day 1 of CHDI’s HD therapeutics conference: exploring abnormal brain connections and silencing the HD gene
Anti-nausea drug meclizine protects cells with the HD mutation from death by reducing cellular energy production
HDBuzz visits Palm Springs to talk with CHDI about the latest HD research. Send us your questions!
Welcome to HDBuzz. Huntington’s disease research news. In plain language. Written by scientists. For the global HD co
Memantine, a drug already used in Alzheimer’s disease, might help in HD, but a mouse study shows dose is everything.
More reasons to be active: a passive lifestyle may contribute to earlier onset of symptoms in HD.
Answers to frequently-asked questions about HD – the first in a regular series of HDBuzz FAQ articles.
New scientific journal PLoS Currents HD promises rapid publication & open access, improving scientific communication
Dimebon – disappointing results in an Alzheimer’s disease trial, but hope remains for HD.